An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
2022-11-21
عنوان الدراسة
An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
داعم الدراسة
Global Blood Therapeutics (GBT)
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-133
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.